|
I.S. Dydykina (1), P.S. Kovalenko (1), A.A. Kovalenko (2)
DIFFERENTIATED APPROACH TO THE SELECTION OF VITAMIN D PREPARATIONS FOR THE TREATMENT OF OSTEOPOROSIS
|
№s3-17 / 2017
|
|
N.V. Toroptsova (1), O.B. Ershova (2), I.E. Zazerskaya (3), O.M. Lesnak (4, 5), L.Ya. Rozhinskaya (6)
VITAMIN D AND CALCIUM DEFICIENCY IN ADULTS: 1000 PROBLEMS - ONE SOLUTION?
|
№s3-17 / 2017
|
|
P.S. Kovalenko, I.S. Dydykina, A.V. Smirnov, S.I. Glukhova, L.I. Alekseeva, E.L. Nasonov
THE EXPERIENCE OF THE USE OF DENOSUMAB IN THE TREATMENT OF PATIENTS WITH RHEUMATOID ARTHRITIS WITH OSTEOPOROSIS
|
№7 / 2017
|
|
I.A. Baranova
ALFACALCIDOL IN TREATMENT OF OSTEOPOROSIS
|
№5 / 2017
|
|
M.E. Telnova, N.A. Petunina
BISPHOSPHONATES IN THE TREATMENT OF OSTEOPOROSIS. EFFICACY AND SAFETY OF IBANDRONATE
|
№5 / 2017
|
|
E.V. Biryukova
MODERN OPPORTUNITIES OF BONE ANABOLIC THERAPY OF OSTEOPOROSIS
|
№5 / 2017
|
|
N.V. Toroptsova, O.A. Nikitinskaya
OSTEOPOROSIS IN REAL CLINICAL PRACTICE: FOCUS ON ALFACALCIDOL
|
№19 / 2016
|
|
I.A. Skripnikova
OSTEOPOROSIS - A PEDIATRIC DISEASE WITH GERONTOLOGICAL CONSEQUENCES. WHEN, WHOM AND HOW TO PREVENT IT?
|
№19 / 2016
|
|
A.V. Pashentseva, A.F. Verbovoy
OSTEOPOROSIS IN MEN
|
№16 / 2016
|
|
S.S. Rodionova, U.R. Khakimov
RATIONALE FOR USE OF ALFACALCIDOL IN COMBINATION WITH BISPHOSPHONATES IN POSTMENOPAUSAL AND SENILE FORMS OF SYSTEMIC OSTEOPOROSIS
|
№s3-16 / 2016
|
|
N.Yu. Karpova (1), M.A.Rashid (2), T.V. Kazakova (1), M.E. Yadrov (2)
CALCIUM METABOLISM AND BONE HOMEOSTASIS
|
№s3-16 / 2016
|
|
N.V. Toroptsova (1), I.A. Baranova (2), O.M. Lesnyak (3, 4)
RECOMMENDATIONS FOR USE OF THE RUSSIAN MODEL FRAX® FOR DETERMINING 10-YEAR PROBABILITY OF OSTEOPOROTIC FRACTURES
|
№s3-16 / 2016
|
Русский
